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Introduction
The Congress of the Polish Society of Nuclear Medicine was
held in Bydgoszcz  from 26–28 May, 2004. In total 101 papers
were presented accompanied by a series of programme lectures
of our foreign guests, a technologists session and a post-con-
gress meeting on PET. As a highlights lecturer I have the pleasure
to summarise some of these presentations.
Endocrinology
An issue of growing importance today is apoptosis. Rogows-
ki and colleagues from Bialystok presented a series of papers on
apoptotic changes following 131I therapy of hypothyreosis.
Two papers were devoted to radioiodine therapy of large-sized
goitres. Listewnik et al. showed that increasing the administered
activity is helpful in middle-sized goitres, with no associated dose-
effect in goitres larger than 29 ml. Bączyk et al. showed good
results of RN treatment in very big goitres (100–370 ml), advocat-
ing fractionated-dose RI therapy.
Traditionally, a series of papers on parathyroid came from CSK
Warsaw centre. Mączewska et al. strongly recommends the intra-
operative use of a hand-held gamma probe (efficacy 70%) in pri-
mary persistent parathyroidism. A nice study, although the num-
ber of patients was small.
Two interesting posters came from  Nowicka et al. from Byd-
goszcz. Firstly, they brought up the simple, yet interesting issue
of the efficacy of radioidine treatment of hyperthyreosis in the el-
derly: in younger patients treatment results came faster, but overall
results were comparable in groups of younger and older patients.
In a second study they analysed the results on RI therapy on
a goitre’s volume, showing a 1/3 decrease in volume 4 mo. post-
treatment. Well, cosmetic results also matter.
Along the same lines, there was also an interesting poster on
the quality of life of patients with orbithopathy pre- and post- RI
treatment by Warmuz et al. from Poznań. Using a complex battery
of psychological tests they did not get conclusive results, but def-
initely this issue is worth continuing to investigate.
Endocrinological oncology
In endocrinological oncology many interesting papers came
from the Institute of Oncology in Gliwice. An interesting series of
35 patients with medullary carcinoma treated with I-131-MIBG was
presented by Szpak et al. A good palliative response was ob-
served in about half of the patients. No such good results were
shown by the other study on 13-cis-retinoic acid  in afunctional
thyroid carcinoma metastases.
Also medullary carcinoma was the focus of a PET study from
Bydgoszcz, done by Pietrzak and colleagues. They showed neg-
ative results in a half of patients. Why? This study would beneficial
if crossed with e.g. 99m-Tc-(V)-DMSA scanning.
A very practical study on the high utility of  a first post-op thy-
roglobulin assay in prognosing thyroid metastases came from Łódź
and Zgierz. Fine statistical work!
An interesting poster on RIT treatment of thyroid carcinoma in
children came from Poznań. In 2/3 of patients ablation came after
the 1st treatment, in remaining 1/3 after the 2nd treatment. This de-
serves further following up.
From the same centre there was a poster on ambulatory thy-
roid cancer radioiodine treatment study using fractionated radio-
iodine doses (30 mCi). The results were promising.
Cardiology
Papers in this section were focused mostly on coronary heart
disease and myocardial infarction.
A very fine, large (181 patients) study on ejection fraction as-
sessed by GSPECT came from the Institute of Cardiology in War-
saw by Teresińska et al. They did a very thorough cross study of
quantitative GSPECT, EMORY Cardiac Toolbox and conventional
RN ventriculography (RNV) in a variety of clinical situations. Well,
is RNV still the winner? From the same centre there came a very
nice paper on I-123-MIBG scanning assessing heart adrenergic
system post laser revascularisation (TMLR). Post-TMLR denerva-
tion may play a role in patients’ clinical course post-op.
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Also a paper to TMLR was presented by Dziuk from Warsaw/
London. This is another interesting voice in the discussion on how
exactly TMLR works. Despite clinical improvement, 201-Tl scan-
ning initially, but not permanently, increased; EF decreasing. Why?
Kostkiewicz and Szot from Cracow assessed the safety of the
dipirydamole stress test in patients with CAD and aortal valve steno-
sis. The issue is old while the model is new. Congratulations! Dziuk,
Canizales and Britton studied with heart perfusion scintigraphy and
an adenosine test a group of patients with non-diagnostic coronar-
ography.  They showed perfusion changes in one third of patients,
with a predictive and risk stratification role of RN studies.
Two interesting posters on the nitroglycerine test came from
Kobylecka et al. from CSK in Warsaw. They underline the role of
the nitroglycerine test in predicting the efficacy of revascularisa-
tion treatment. On the other hand, nitroglycerine action seems to
be highly heterogeneous, exerting an increase of myocardial per-
fusion as well as a steal-effect
An interesting phenomenon of rest-deterioration of heart per-
fusion was analysed in a poster by Dąbrowski et al. from Warsaw.
In a sound material of 81 pts they showed this effect mostly in the
arterial beds with little or no effect by arrteriosclerosis. Are these
microcirculation changes or the steal phenomenon?
Cholewiński et al. from Lublin showed post-stress myocardial stun-
ning in patients with CAD by means of GSPECT. From the same group
there came a poster on natriuretic peptide in patients with CAD.
A very interesting poster was presented by a group by Simi-
nak  from Lublin. They analysed the distribution of 111-In labelled
cells autotransplanted in patients with myocardial infarction
— a ne2 modality of MI treatment. The results were somewhat not
entirely conclusive, but the goal of this paper seems to be very
interesting.
Oleksa et al. from Poznań showed an impaired chronotropic
reaction to dipirydamole in diabetic patients — something per-
sonally close to the heart of this note’s author, who did his M.D.
on adrenergic reactivity in diabetes some years ago.
A interesting paper by Stefaniak et al. on the application of
a artificial neural network in prognosing GSPECT ejection fraction
came from Lublin. Artificial intelligence support in clinical deci-
sion-making is a growing challenge for today and tomorrow.
Oncology
Oncological papers were focused mostly, but not only on “hot”
issues of lymphoscintigraphy and peptide imaging.
Sentinel node
Regarding lymphoscintigraphy, Nejc and colleagues from Łódź
underlined the importance of lymphoscintigraphy in truncal mela-
noma — moreover, they consider it absolutely necessary. Not very
ground-breaking, to put it frankly, but fine material (120 patients),
and a study of good practical importance. Similar remarks were
made in a poster by Birkenfeld et al.
Jastrzębski et al. from Gdańsk analysed a large series of sen-
tinel node identification in 195 breast cancer patients. They advo-
cate peri-areolar administration of tracer, similarly as Nejc et al. in
their another paper.
An issue of growing importance is sentinel node identification
in gynaecological patients. A paper by Wydra et al. from Gdańsk
showed a high, but not strikingly high sensitivity of RN studies,
when compared with the blue dye technique.
The same goal but a different model. Sentinel node in oral
cavity carcinomas — paper by Nowaczyk and Wyszomirska from
Poznań. Fine results, but the authors were discussing breast and
pelvic carcinomas probably by editorial error. Sentinel node iden-
tification performed in pharyngeal carcinoma was presentd by
Gołębiewska et al. from Lublin.
Another model — penal carcinoma case study also by Nejc et al.
Well, are we going back to the beginnings of lymphoscintigraphy?
Another goal: SN in GI tract tumours — described nicely by
a group led by Hubalewska from Cracow. Hopefully, their number
of patients soon will be growing to more than 5.
A short but important paper from Gdańsk, by Jastrzębski et al.
assessed staff radiation safety in intra-operation SN determina-
tion. The absorbed dose was far below all limits. Nothing makes
nothing. A little item, but a nice tool to combat radiophobia.
Neuroendocrine tumours/peptides
Płachcińska and colleagues from Łodź, made a very thorough
study of 99m-EDDA/HYNIC-Tyr3-octreotide in solitary lung tumours
using ROC curves. They had very good results in malignant tu-
mours, less promising in benign ones. Quatitative analysis did not
particularly improve the outcome. A similar study came from the
Oncological Institite from Warsaw.
Hubalewska et al. advocate the superiority of 99m-Tc-Octreo-
tate over 111-In-Octreoscan and 131-MIBG in imaging of those
tumours. It could be very good news.
Szaluś et al. made a fusion of 99m-Tc-Depreotide and CT im-
ages in lung carcinoma. Fine technical work ! How nice is to have
a Hermes workstation...
Budlewski et al. from Bialystok analysed the prognostic role of
131-I-MIBG imaging in neuroblastoma in children.
Others
A fusion imaging study came also from Łódź by Górska-
-Chrząstek et al. They fused methyl-tyrosine brain tumours SPECT
and MR imaging with excellent results. This seems to be an inter-
esting alternative to PET.
This thesis might be supported by a series of PET brain tu-
mour scans by Szefer et al. from Bydgoszcz — in low malignancy
recurrence the results were not very impressive.
Chrapko and colleagues analysed the levels of bone turn-over
markers PINP and ICTP in bone metastases.
Therapy
An interesting question was posed by Kolodziejczyk and Zebrows-
ki from Wroclaw — is RN treatment of bone metastases effective in
neoplasms other than breast and prostate carcinoma. The authors’
answer is no, but the question is probably far from being elucidated.
A number of other studies was devoted to the same topic, i.e.
RN bone metastases treatment: by Birkenfeld from Szczecin, by
Gołąb from Tychy, by Bączyk from Poznań. This common marker
is generally lower than in world literature. Are Polish patients re-
ferred too late for RN treatment or something is wrong with our
strontium or samarium?
Buscombe, Ćwikła et al. from London/Warsaw analysed the
efficiency of 111-In and 90-Y peptide therapy in neuroendocrine
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tumours, as compared with 131-I-MIBG therapy. There were no
differences in survival time. Why? However, the next paper from
the same group showed very good prolonged survival.
Neurology
In contrary to world tendencies, which has also been observed
at recent Polish SNM congresses, the number of NM neurological
papers has been increasing.
Two papers were devoted to RN imaging in Parkinson’s dis-
ease (PD). Chmielowski et al. from Warsaw presented a report on
I123-FP-CIT in Parkinson’s disease in 8 patients with parkinsonian
syndromes. They concluded that there is a high usability of this
testing in PD. A group led by Derejko from Gdansk performed
rCBF SPECT in PD patients with and without dementia. Their re-
sults indicate rCBF changes indicating mixed, vascular/neurode-
generative background of dementia in PD.
From the same centre came a paper by Jodzio et al. on post-
stroke aphasias and rCBF SPECT, which has proven to be useful
not only in assessing the cortical damage, but associated neu-
ronal loops as well.
An interesting paper, performed jointly with one of the best
Polish neurosurgical centres came from Lublin. Nocuń et al. as-
sessed perfusion changes close to and around cerebral artery
aneurysm, just before embolisation — a nice tool to assess the
range of CBF changes in those patients.
Pach and colleagues from Cracow reported an interesting re-
port of rCBF SPECT scanning in familial lead tetra-ethylate poi-
soning. Multiple rCBF defects were not visible by CT, and con-
firmed only by MR spectroscopy months later.
A very nice study on brain image MR/SPECT fusion came from
Łódź by Grzelak and colleagues — very important not exactly for
its scientific advances, but a modern and intradisciplinary approach
to CNS imaging, which is still rare in Poland.
Digestive tract
A study on radionuclide transit in bowel-reconstructed oesoph-
agus came from CZD in Warsaw by Świątek et al. From the same
centre came an interesting paper on MBrIDA scanning deconvo-
lution anlysis in infants with bile atresia.
Pilecki and colleagues from Bydgoszcz reported an interesting
case report on RN studies of post-traumatic auto-transplantation
of splenic tissue in the abdominal cavity. Another interesting case of
cholescintigraphy in Siamese twins was reported from Warsaw by Kijek.
The papers on IDA clearance by Surma and Frieske  came
from Łódź. Technically perfect, as usual but frankly speaking. I would
like to know what the practical importance of IDA clearance is.
Elbl, Birkenfeld and colleagues (Szczecin) showed an elegant
cross-study of oesophageal passage and reflux, gastric empty-
ing and a battery of GE diagnostic tests in children with bronchial
asthma. Still endoscopy proved to be the best, but a multidisci-
plinary approach is to be recommended.
Kidneys
A interesting study in paediatric nephrology came from Łódź.
In a large amount of material they assessed reproducibility of
99mTc-unithiol static and SPECT kidney scans using two different
scales by Goldraich and Howard. From the same centre was
a paper on renal scars in youngsters with diabetes mellitus. They
showed a two-fold bigger frequency of scars in DM, already at
a young age. Better  reproducibility results were achieved in pla-
nar than in static imaging. Why? In an interesting study from Lub-
lin Chrapko and colleagues showed the importance of dynamic
renal scintigraphy in patients following percutaneous lithotripsy.
This very important paper would benefit patients a lot, if compared
with the results of other urological operations.
Bone and joints
A group by Grabowski et al. from Siedlce analysed with
3-phase bone scintigraphy a large series of 83 children with hip
pain. This study underlines the importance of this study in paedi-
atric orthopedics.
In a case of histiocytosis, Pilecki et al. analysed CT/RN imag-
ing correlations.
Angiology, lymphoscintigraphy,
veno-scintigraphy
Dąbrowa et al. from Łódź showed impaired lymph circulation
in a crural venous ulcer. A nice study, but, well, was the result not
obvious? Stępień and colleagues (Cracow) proposed 99mTc-la-
belled-IgG as a lymphoscintigraphic agent. A fine study, but it
would benefit from comparison with traditional lymphoscintigraphic
radiopharmaceuticals, which was not performed.
From the same centre came an interesting paper on in-vivo-
labelled erythrocytes in venous drainage disturbances. A fine study
which could be promising in performing RN venography in pa-
tients with oedema.
A group by Dąbrowski et al from Łódź strongly advocates
stress/rest limb MIBI scanning in lower limbs arteriosclerosis, pos-
itive well before positive Doppler US results.
Infection and inflammation
Birkenfeld and colleagues underlined the importance of
HMPAO-labelled leukocyte scanning in children with unspecific
colitis. Stępień and Pawlus from Cracow underlined the impor-
tance of vascular phase of 99mT-IgG inflammation imaging. The
focal tracer’s early accumulation could be predictive for positive
scans in the delayed phase.
Radiopharmaceuticals
This undoubtedly was a strong section of this Congress.
An interesting proposal of labelling DOTATATE with 177-Lu
and 90-Y came from the group of Pawlak and co-workers from
POLATOM. A conjugate of IgG-HYNIC could be a promising in-
flammation imaging agent (Michalik et al. from Warsaw), also
technetium--99m-labelled interleukin (Karczmarczyk et al. from
POLATOM).
I-123 and I-123 labelled methyl-thyrosine was synthesised by
a group of Zakrzewska et al from POLATOM. An interesting stud-
ies on tumoural angiogenesis imaging by monoclonal antibodies
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anti-CD61 — 131-I was presented by Bilski and colleagues from
Warsaw. Technetium labelled recombinant human TSH could be
an interesting marker for the imaging of differentatiated thyroid
carcinoma metastases (Byszewska et al.). Radionuclide complex-
es of platinum (IV) with [131-I/131I]histamine (papers by Maurin
and Garnuszek) could be an interesting challenge in RN therapy.
A method of obtaining 188-Re-perrhenate was also described
by Karczmarczyk.
Radioprotection and dosimetry
A series of reports on radioprotection came from the Military
Institute of Hygiene and Epidemiology in Warsaw. Jaźwiński and
Janiak compared absorbed doses of radiation in Army vs. Police
hospitals nuclear medicine departments. Why this choice of interes-
ting model?
Some reports were devoted to thermo-luminescence dosi-
metry. Rorat et al. from Cracow assessed it when applied to po-
siton emission by 48V. Well, what are the practical conclusions?
Thermo-luminescence was also strongly advocated by Jaźwiński
from Warsaw.
An interesting paper by Bajera and colleagues from Warsaw
showed the possible negative influence of 131J therapeutic-dose-
-administered-patients on gamma-camera acquisition parameters.
Well, this is bad news for the users of small NM departments
— patients walking on the corridor and blinding gammacamera
rays coming through the wall.
Conclusive remarks
There were two types of news which came from this survey
which can be simply divided into good and bad:
— good: despite the incredible mess created by the unfortunate
reform of our health sector in Poland, nuclear medicine has
survived and is scientifically productive;
— another good thing is that interesting and fresh ideas still mat-
ter, even if when competing with the increasing high-tech
of the modern world’s nuclear medicine;
— bad: how long time? Even in the era of high-tech, PET, ultra-
modern radiopharmacy etc, etc. originality in science will not
last for ever.
This is an increasing challenge for Polish nuclear medicine.
